BioAdaptives Q1 2025: $9M Revenue, $125M Assets
Ticker: BDPT · Form: 10-Q · Filed: May 13, 2025 · CIK: 1575142
| Field | Detail |
|---|---|
| Company | Bioadaptives, INC. (BDPT) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, preferred-stock
TL;DR
BioAdaptives Q1 2025: $9M revenue, $125M assets, $8.2M liabilities. Stock activity noted.
AI Summary
BioAdaptives, Inc. filed its Q1 2025 10-Q report for the period ending March 31, 2025. The company reported revenue of $9,048,659. Key financial figures include total assets of $125,000,000 and total liabilities of $8,215,426. The filing also details preferred stock issuances, including Series D Preferred Stock on July 4, 2024, and Series C Preferred Stock on January 24, 2022.
Why It Matters
This filing provides a snapshot of BioAdaptives' financial health and operational performance in the first quarter of 2025, offering insights into its revenue generation and asset base.
Risk Assessment
Risk Level: medium — The company has significant preferred stock activity and a relatively small amount of reported liabilities compared to assets, which could indicate complex financial structures or early-stage growth.
Key Numbers
- $9.05M — Revenue (Q1 2025 Revenue)
- $125.0M — Total Assets (As of March 31, 2025)
- $8.2M — Total Liabilities (As of March 31, 2025)
Key Players & Entities
- BIOADAPTIVES, INC. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- $9,048,659 (dollar_amount) — Q1 2025 Revenue
- $125,000,000 (dollar_amount) — Total Assets
- $8,215,426 (dollar_amount) — Total Liabilities
- Series D Preferred Stock (company) — Preferred Stock Type
- 2024-07-04 (date) — Series D Preferred Stock Date
- Series C Preferred Stock (company) — Preferred Stock Type
- 2022-01-24 (date) — Series C Preferred Stock Date
FAQ
What was BioAdaptives, Inc.'s revenue for the first quarter of 2025?
BioAdaptives, Inc. reported revenue of $9,048,659 for the period ending March 31, 2025.
What were the total assets and liabilities of BioAdaptives, Inc. as of March 31, 2025?
As of March 31, 2025, BioAdaptives, Inc. had total assets of $125,000,000 and total liabilities of $8,215,426.
When was the Series D Preferred Stock issued?
The Series D Preferred Stock was issued on July 4, 2024.
What is the SIC code for BioAdaptives, Inc.?
The Standard Industrial Classification (SIC) code for BioAdaptives, Inc. is 2834, Pharmaceutical Preparations.
What was the former name of BioAdaptives, Inc. and when did the name change occur?
The former name of BioAdaptives, Inc. was APEX 8 Inc., and the name change occurred on April 24, 2013.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding BIOADAPTIVES, INC. (BDPT).